Conclusion The functionaltest of LAAT might be superior tototalwhite blood cell countinassessingacutephase response after acute bacterialinfection in children.
Also today, Trius Therapeutics (TSRX) said a phase 3 trial of its tedizolid phosphate treatment for bacterial skin and skin structure infections met its primary endpoint.